References
Steen VM et al. Mol Psychiatry 1997 2: 139–145
Segman R et al. Mol Psychiatry 1999 4: 247–253
Basile V et al. Neuropsychopharmacology 1999 21: 17–27
Løvlie R et al. Int J Neuropsychopharmacol 2000 3: 61–65
Rietschel M et al. Eur Arch Psychiatry Clin Neurosci 2000 250: 31–35
Eichhammer P et al. Am J Med Genet 2000 96: 187–191
McCreadie RG et al. Br J Psychiatry 1996 168: 221–226
Fenton WS et al. Arch Gen Psychiatry 1994 51: 643–650
Cassady SL et al. Am J Psychiatry 1998 155: 70–75
Gervin M et al. Am J Psychiatry 1998 155: 1202–1206
Kay SR et al. Schizophrenia Bull 1987 13: 262–273
Guy W (ed) . ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76-338 US Department of Health, Education and Welfare: Washington, DC 1976 pp 534–537
Schooler NR, Kane JM . Arch Gen Psychiatry 1982 39: 486–487
Lannfelt L et al. Psychiatr Genet 1992 2: 249–256
Dubertret C et al. Am J Med Genet 1998 81: 318–322
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Løvlie, R., Thara, R., Padmavathi, R. et al. Ser9Gly dopamine D3 receptor polymorphism and spontaneous dyskinesia in never-medicated schizophrenic patients. Mol Psychiatry 6, 6–7 (2001). https://doi.org/10.1038/sj.mp.4000822
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4000822
- Springer Nature Limited